CSS LLC’s AMAG Pharmaceuticals AMAG Stock Holding History

CSS LLC’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,796	Closed	-$34.2K	–	596
2018 Q3	$36K	Buy	+1,796	New	+$40.9K	﹤0.01%	520
2017 Q4	–	Sell	-4,500	Closed	-$83K	–	670
2017 Q3	$83K	Buy	+4,500	New	+$83.9K	﹤0.01%	566

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CSS LLC's AMAG Position: Q4 2018 in Review

CSS LLC sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 1,796 shares — an estimated $34.2K sold.

CSS LLC first reported a position in AMAG in Q3 2017 and held it in 2 quarters. The position peaked at $83K in Q3 2017. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

CSS LLC reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
CSS LLC sold 1,796 AMAG Pharmaceuticals shares in Q4 2018, an estimated $34.2K.
CSS LLC first reported a position in AMAG Pharmaceuticals in Q3 2017 and held it in 2 quarters.
CSS LLC's AMAG Pharmaceuticals position peaked at $83K in Q3 2017.
190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on CSS LLC's 13F filing for Q4 2018, filed 14 Feb 2019.